Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IRGENOMICS

Financiado

Cerrado

Genetical genomics of type 2 diabetes and cardiovascular phenotypes in experimen...

Genetical genomics of type 2 diabetes and cardiovascular phenotypes in experimental systems The objectives of this proposal are to establish causal relationships between altered gene expression regulation and diabetes metabolic changes in a rat model of spontaneous insulin resistance, the Goto-Kakizaki (GK) strain, and d... ver más

31/12/2010

UOXF

178K€

Presupuesto del proyecto: 178K€

Líder del proyecto

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2010-12-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UOXF

0.00€ | Lider

Proyectos interesantes

T2DSystems

Medical Technol...

Data Science

6M€ Cerrado

Reg-Seq

Medical Technol...

Data Science

2M€ Cerrado

OpiO

Medical Technol...

Data Science

2M€ Cerrado

SAF2008-03803

Medical Technol...

Data Science

847K€ Cerrado

BFU2012-33594

Medical Technol...

Data Science

47K€ Cerrado

GLUCOSEGENES

Medical Technol...

Data Science

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 178K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The objectives of this proposal are to establish causal relationships between altered gene expression regulation and diabetes metabolic changes in a rat model of spontaneous insulin resistance, the Goto-Kakizaki (GK) strain, and define disease-associated biomarkers. This multidisciplinary research addresses fundamental questions concerning the impact of naturally-occurring genetic variants on metabolic regulations contributing to diabetes and obesity, which have become dominant causes of reduced life expectancy in westernized societies. The proposed research builds on knowledge of genetic loci linked to variables relevant to insulin resistance and quantitative changes in metabolites derived by metabonomics, as well as advances in functional genomic technologies and expanding rat genomic resources (genome sequence, single nucleotide polymorphism - SNP). This research takes advantage of the availability of congenic strains of the GK rat, which are powerful tools for validating results from genetic and genetical genomic experiments and testing hypotheses regarding the involvement of SNPs in disease features. In this programme gene transcription profiling, bioinformatic tools and metabolic and biochemical studies will be applied in existing congenic strains of the GK rat carrying chromosomal regions of a locus associated with insulin resistance, transferred onto the genetic background of a control strain. Gene pathways and networks associated with altered metabolic variables will be correlated with SNP-derived haplotypes of the parental strains across the congenic intervals in order to fine map the causative genetic variant(s). This strategy, which integrates different mechanistic levels of gene expression (transcriptome and metabonome), will define biomarkers associated with or predicting disease onset and progression and provide key information for identifying the underlying genes. Results will provide improved knowledge for therapeutic targets and disease prevention.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores